Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Esnault

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1975
[Cytophotometric determination of the relative amounts of deoxyribonucleic acid in the nuclei of blastocysts during normal and retarded implantation in the rat]H Dupont, C Esnault, A J Duluc, et al.
Biochimie|January 1, 1987
The relationship between HDL-, LDL-, liposomes-free cholesterol, biliary cholesterol and bile salts in the ratC Esnault-Dupuy, F Chanussot, H LaFont, et al.
Cancer Research|October 1, 1984
Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cellsC Esnault, B P Roques, A Jacquemin-Sablon, et al.
Oncogene|October 1, 1990
SV40 induced cellular immortalization: phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell lineB Mignotte, J C Larcher, D Q Zheng, et al.
Genes and Immunity|May 23, 2003
Linkage and association between Plasmodium falciparum blood infection levels and chromosome 5q31-q33L Flori, B Kumulungui, C Aucan, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chainC Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
Cancer Research|November 1, 1986
Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase IIJ Markovits, Y Pommier, M R Mattern, et al.
Anti-Cancer Drug Design|February 1, 1990
Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactionsB Lambert, E Segal-Bendirdjian, C Esnault, et al.
Biochemical Pharmacology|January 1, 1990
Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agentC Esnault, S C Brown, E Segal-Bendirdjian, et al.
Annales De Dermatologie Et De Venereologie|May 16, 2009
[Brachioradial pruritus revealing an ependymoma]C Fleuret, D Dupré-Goetghebeur, H Person, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1975
[Cytophotometric determination of the relative amounts of deoxyribonucleic acid in the nuclei of blastocysts during normal and retarded implantation in the rat]H Dupont, C Esnault, A J Duluc, et al.
Biochimie|January 1, 1987
The relationship between HDL-, LDL-, liposomes-free cholesterol, biliary cholesterol and bile salts in the ratC Esnault-Dupuy, F Chanussot, H LaFont, et al.
Cancer Research|October 1, 1984
Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cellsC Esnault, B P Roques, A Jacquemin-Sablon, et al.
Oncogene|October 1, 1990
SV40 induced cellular immortalization: phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell lineB Mignotte, J C Larcher, D Q Zheng, et al.
Genes and Immunity|May 23, 2003
Linkage and association between Plasmodium falciparum blood infection levels and chromosome 5q31-q33L Flori, B Kumulungui, C Aucan, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chainC Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
Cancer Research|November 1, 1986
Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase IIJ Markovits, Y Pommier, M R Mattern, et al.
Anti-Cancer Drug Design|February 1, 1990
Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactionsB Lambert, E Segal-Bendirdjian, C Esnault, et al.
Biochemical Pharmacology|January 1, 1990
Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agentC Esnault, S C Brown, E Segal-Bendirdjian, et al.
Annales De Dermatologie Et De Venereologie|May 16, 2009
[Brachioradial pruritus revealing an ependymoma]C Fleuret, D Dupré-Goetghebeur, H Person, et al.
Pageof 3